Quidelortho share price today

(QDEL)

Quidelortho share price is $41.52 & -₹41.52 as on 12 Dec 2024, 2.30 'hrs' IST

$41.52

▲

3.02

(7.84%)

Market is closed - opens 8 PM, 12 Dec 2024

View live Quidelortho share price in Dollar and Rupees. Guide to invest in Quidelortho from India. Also see the sentimental analysis on Indian investors investing in Quidelortho. Get details on the Indian mutual funds that are investing in Quidelortho. Get Analyst recommendations and forecasts along with all the Quidelortho's financials.

Quidelortho share price movements

$39.40
$41.61
$41.52
5.12%
Downside
Day's Volatility :5.32%
Upside
0.22%
$29.74
$75.86
$41.52
28.38%
Downside
52 Weeks Volatility :60.8%
Upside
45.26%

Quidelortho Returns

Period	Quidelortho Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-7.32%	-8.8%	0.0%
6 Months	11.25%	-2.7%	0.0%
1 Year	-41.16%	6.5%	0.0%
3 Years	-70.64%	5.6%	-20.0%

Quidelortho Key Statistics

in dollars & INR

Previous Close	$38.5
Open	$39.65
Today's High	$41.61
Today's Low	$39.395
Market Capitalization	$2.8B
Today's Volume	$832.4K
52 Week High	$75.855
52 Week Low	$29.735
Revenue TTM	$2.8B
EBITDA	$586.5M
Earnings Per Share (EPS)	$-27.81
Profit Margin	-66.25%
Quarterly Earnings Growth YOY	-0.77%
Return On Equity TTM	-45.79%

How to invest in Quidelortho from India?

It is very easy for Indian residents to invest directly in Quidelortho from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Quidelortho stock in both rupees (INR) and dollars (USD). Search for Quidelortho or QDEL on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Quidelortho or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Quidelortho shares which would translate to -0.000 fractional shares of Quidelortho as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Quidelortho

150%

Period: Sep 12, 2024 to Dec 11, 2024. Change in 30 Days versus previous period

Search volume for Quidelortho on INDmoney from India has grown in the last 30 days as on Dec 12, 2024. 150% more investors are searching Quidelortho in the last 30 days versus the previous period.

Global Institutional Holdings in Quidelortho

T. Rowe Price Investment Management,Inc.
13.97%
The Carlyle Group Inc
12.28%
Vanguard Group Inc
9.00%
BlackRock Inc
7.28%
Rubric Capital Management LP
6.24%
Amvescap Plc.
2.99%

Analyst Recommendation on Quidelortho

Buy

61%Buy

30%Hold

7%Sell

Based on 13 Wall street analysts offering stock ratings for Quidelortho(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Quidelortho

What analysts predicted

Upside of 24.04%

Current:

$41.52

Target:

$51.50

Insights on Quidelortho

Price Movement
In the last 7 days, QDEL stock has moved up by 10.4%
Increasing Revenue
Revenue is up for the last 2 quarters, 636.3M → 727.1M (in $), with an average increase of 12.5% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -1.70B → -19.9M (in $), with an average increase of 848.6% per quarter
QDEL vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 61.9% return, outperforming this stock by 98.6%
QDEL vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 120.0% return, outperforming this stock by 189.0%
Price to Sales
ForQDEL every $1 of sales, investors are willing to pay $1.0, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Quidelortho Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$522.3M	↑ 88.05%
Net Income	$74.2M	↓ 1008.55%
Net Profit Margin	14.2%	↑ 17.14%

	FY19	Y/Y Change
Revenue	$534.9M	↑ 2.41%
Net Income	$72.9M	↓ 1.7%
Net Profit Margin	13.63%	↓ 0.57%

	FY20	Y/Y Change
Revenue	$1.7B	↑ 210.66%
Net Income	$810.3M	↑ 1011.18%
Net Profit Margin	48.76%	↑ 35.13%

	FY21	Y/Y Change
Revenue	$1.7B	↑ 2.22%
Net Income	$704.2M	↓ 13.09%
Net Profit Margin	41.46%	↓ 7.3%

	FY22	Y/Y Change
Revenue	$3.3B	↑ 92.28%
Net Income	$548.7M	↓ 22.08%
Net Profit Margin	16.8%	↓ 24.66%

	FY23	Y/Y Change
Revenue	$3.0B	↓ 8.34%
Net Income	$-10.1M	↓ 101.84%
Net Profit Margin	-0.34%	↓ 17.14%

	Q2 FY23	Q/Q Change
Revenue	$665.1M	↓ 21.39%
Net Income	$-53.2M	↓ 209.02%
Net Profit Margin	-8.0%	↓ 13.77%

	Q3 FY23	Q/Q Change
Revenue	$744.0M	↑ 11.86%
Net Income	$-12.7M	↓ 76.13%
Net Profit Margin	-1.71%	↑ 6.29%

	Q4 FY23	Q/Q Change
Revenue	$742.6M	↓ 0.19%
Net Income	$7.0M	↓ 155.12%
Net Profit Margin	0.94%	↑ 2.65%

	Q1 FY24	Q/Q Change
Revenue	$709.7M	↓ 4.43%
Net Income	$-1.7B	↓ 24471.43%
Net Profit Margin	-240.38%	↓ 241.32%

	Q2 FY24	Q/Q Change
Revenue	$636.3M	↓ 10.34%
Net Income	$-147.7M	↓ 91.34%
Net Profit Margin	-23.21%	↑ 217.17%

	Q3 FY24	Q/Q Change
Revenue	$727.1M	↑ 14.27%
Net Income	$-19.9M	↓ 86.53%
Net Profit Margin	-2.74%	↑ 20.47%

	FY18	Y/Y Change
Total Assets	$806.4M	↓ 13.78%
Total Liabilities	$380.8M	↓ 46.23%

	FY19	Y/Y Change
Total Assets	$910.9M	↑ 12.96%
Total Liabilities	$351.0M	↓ 7.81%

	FY20	Y/Y Change
Total Assets	$1.9B	↑ 105.43%
Total Liabilities	$538.5M	↑ 53.39%

	FY21	Y/Y Change
Total Assets	$2.4B	↑ 29.89%
Total Liabilities	$501.0M	↓ 6.95%

	FY22	Y/Y Change
Total Assets	$8.9B	↑ 264.38%
Total Liabilities	$3.9B	↑ 682.66%

	FY23	Y/Y Change
Total Assets	$8.6B	↓ 3.31%
Total Liabilities	$3.6B	↓ 9.28%

	Q2 FY23	Q/Q Change
Total Assets	$8.6B	↓ 2.69%
Total Liabilities	$3.5B	↓ 6.41%

	Q3 FY23	Q/Q Change
Total Assets	$8.5B	↓ 0.13%
Total Liabilities	$3.6B	↑ 0.69%

	Q4 FY23	Q/Q Change
Total Assets	$8.6B	↑ 0.28%
Total Liabilities	$3.6B	↓ 0.43%

	Q1 FY24	Q/Q Change
Total Assets	$6.7B	↓ 21.72%
Total Liabilities	$3.4B	↓ 4.54%

	Q2 FY24	Q/Q Change
Total Assets	$6.7B	↓ 0.21%
Total Liabilities	$3.5B	↑ 3.54%

	Q3 FY24	Q/Q Change
Total Assets	$6.8B	↑ 1.67%
Total Liabilities	$3.6B	↑ 2.81%

	FY18	Y/Y Change
Operating Cash Flow	$136.3M	↑ 392.06%
Investing Cash Flow	$115.0M	↓ 126.62%
Financing Cash Flow	$-244.1M	↓ 190.19%

	FY19	Y/Y Change
Operating Cash Flow	$134.5M	↓ 1.36%
Investing Cash Flow	$-27.2M	↓ 123.69%
Financing Cash Flow	$-98.3M	↓ 59.73%

	FY20	Y/Y Change
Operating Cash Flow	$629.8M	↑ 368.28%
Investing Cash Flow	$-63.3M	↑ 132.55%
Financing Cash Flow	$-130.3M	↑ 32.55%

	FY21	Y/Y Change
Operating Cash Flow	$805.9M	↑ 27.96%
Investing Cash Flow	$-319.5M	↑ 404.61%
Financing Cash Flow	$-173.2M	↑ 32.93%

	FY22	Y/Y Change
Operating Cash Flow	$885.3M	↑ 9.86%
Investing Cash Flow	$-1.6B	↑ 414.57%
Financing Cash Flow	$252.0M	↓ 245.52%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-30.6M	↓ 116.2%
Investing Cash Flow	$-42.3M	↓ 38.61%
Financing Cash Flow	$-99.7M	↑ 67.28%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$41.5M	↓ 235.62%
Investing Cash Flow	$-21.3M	↓ 49.65%
Financing Cash Flow	$-48.7M	↓ 51.15%

Quidelortho Technicals Summary

Sell

Neutral

Buy

Quidelortho is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Quidelortho Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Quidelortho Corp	0.92%	11.25%	-41.16%	-70.64%	-41.55%
Stryker Corporation	-2.83%	9.66%	26.0%	44.64%	84.17%
Boston Scientific Corp.	2.07%	17.67%	60.34%	118.59%	100.35%
Edwards Lifesciences Corp.	12.16%	-15.81%	-1.87%	-38.87%	-5.76%
Abbott Laboratories	-1.98%	10.33%	6.42%	-16.05%	32.11%
Medtronic Plc	-6.09%	1.54%	1.25%	-26.53%	-27.61%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Quidelortho Corp	9.72	NA	7.19	1.8	-0.46	0.01	NA	47.42
Stryker Corporation	40.97	40.97	2.66	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	74.55	74.55	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.34	28.5	6.74	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	35.11	35.11	2.23	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	26.38	25.56	1.53	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Quidelortho Corp	Buy	$2.8B	-41.55%	9.72	-66.25%
Stryker Corporation	Buy	$145.9B	84.17%	40.97	16.34%
Boston Scientific Corp.	Buy	$132.9B	100.35%	74.55	11.26%
Edwards Lifesciences Corp.	Buy	$43.3B	-5.76%	28.34	65.86%
Abbott Laboratories	Buy	$200.3B	32.11%	35.11	13.99%
Medtronic Plc	Buy	$110.6B	-27.61%	26.38	12.06%

About Quidelortho

QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.

Organization	Quidelortho
Employees	7100
CEO	Mr. Joseph M. Busky CPA
Industry	Health Technology

Management People of Quidelortho

Name	Title
Mr. Joseph M. Busky CPA	Chief Financial Officer
Dr. Werner Kroll Ph.D.	Executive Officer
Mr. Brian J. Blaser	President, CEO & Director
Mr. Philip McLellan	Chief Operations Officer
Mr. Jonathan Siegrist Ph.D.	Executive VP of Research & Development and CTO
Ms. Juliet C. Cunningham	Vice President of Investor Relations
Ms. Michelle A. Hodges J.D.	Chief Legal Officer
Mr. Ronald Lee Bowman	Chief Human Resources Officer
Mr. William J. Ferenczy	Point of Care Business Unit Leader
Ms. Tamara A. Ranalli	Molecular Diagnostics Business Unit Leader

Important FAQs about investing in Quidelortho from India :

What is Quidelortho share price today?

Quidelortho (QDEL) share price today is $41.52.

Can Indians buy Quidelortho shares?

Yes, Indians can invest in the Quidelortho (QDEL) from India.

With INDmoney, you can buy Quidelortho at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Quidelortho at zero transaction cost.

How can I buy Quidelortho shares from India?

It is very easy to buy Quidelortho from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Quidelortho be purchased?

Yes, you can buy fractional shares of Quidelortho with INDmoney app.

What are the documents required to start investing in Quidelortho stocks?

To start investing in Quidelortho, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.